Dublin, Aug. 11, 2025 (GLOBE NEWSWIRE) -- The "Novacyt SA (ALNOV) - Product Pipeline Analysis, 2025 Update" has been added to ResearchAndMarkets.com's offering.
Novacyt SA (Novacyt) stands at the forefront of medical diagnostics, specializing in the development and marketing of in vitro and molecular diagnostic products across microbiology, hematology, and serology. Renowned for their cutting-edge genesig q16 and q32 real-time PCR instruments and the MyGo qPCR instrument, Novacyt markets its innovative products under the well-recognized brands MyGo and genesig. The company emphasizes critical clinical areas, addressing diseases like respiratory and gastrointestinal illnesses, insect-borne diseases, sexually transmitted infections (STIs), nosocomial infections, tropical fevers, and hepatitis viruses.
Headquartered in Velizy Villacoublay, Ile-de-France, France, with operational links in France and the United Kingdom, Novacyt collaborates with healthcare professionals and governments, and serves individuals globally. This digital press release offers a vibrant insight into the company's pipeline products portfolio, presenting valuable data and actionable intelligence. Empower your strategic decision-making with detailed analysis of Novacyt's major products and brands.
Report Scope:
- Comprehensive company profile including business description, key facts, major products and services, principal competitors, and recent developments.
- Analysis of pipeline products under development, categorized by equipment type, indication, development stage, and trial status.
- Detailed information on each pipeline product covering territory, development stage, device class, regulatory path, indication(s), application(s), and estimated launch date.
- Thorough descriptions of the products in development, including technical specifications and functions.
- Overview of ongoing clinical trials, featuring trial name, objective, sponsor, design, status and phase, along with estimated start and end dates, where applicable.
Reasons to Buy:
- Formulate business strategies by tapping into emerging trends and developments shaping the medical devices pipeline and technology landscape.
- Enhance product development, marketing, and sales strategies through insights into competitor portfolios.
- Design effective Research & Development strategies for future growth.
- Expand market presence by crafting timely market-entry and market expansion strategies.
- Identify and leverage in-licensing and out-licensing opportunities for enhanced returns.
- Execute strategic mergers and acquisitions by pinpointing key pipeline players.
- Recognize emerging competitors with strong product portfolios and devise competitive counter-strategies.
- Monitor competitors' pipeline products, focusing on status and prospective launch, to bolster competition strategies.
- Identify, understand, and capitalize on high-value products destined to enhance a competitor's portfolio.
Key Topics Covered:
- Novacyt SA Company Overview
- Novacyt SA Pipeline Products and Ongoing Clinical Trials Overview
- Novacyt SA Pipeline Products by Development Stage
- Novacyt SA Pipeline Products Overview
- Diagnostic Assays
- Diagnostic Assay - Aspergillus
- Diagnostic Assay - Pneumocystis
- Genesig Tests
- Genesig - Cytomegalovirus Test
- Genesig Kit - Human Papillomavirus 14
- Genesig q24
- COVID-19 Tests
- LAMP COVID-19 Test
- Next Generation Lateral Flow Test - COVID-19
- PathFlow Tests
- PathFlow COVID-19 Rapid Antigen Pro
- PathFlow COVID-19 Rapid Antigen Self-Test
- PathFlow SARS-CoV-2 Antigen Self-Test
- PathFlow SARS-CoV-2 SMART IgG Test
- Other Products
- Direct-To-PCR Extraction Device
- Multiplex Test - Mosquito-Borne Diseases
- Onconostica
- PROmate SARS-CoV-2 E484K Test
- Single Nucleotide Polymorphism Assay
- Two-Gene Target PROmate Test
- Novacyt SA - Key Competitors
- Novacyt SA - Key Employees
- Novacyt SA - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Appendix
- Methodology
- About the Analyst
A selection of companies mentioned in this report includes, but is not limited to:
- Anagenesis Biotechnologies SAS
- AgCom biotech S.A.R.L.
- Stilla Technologies SAS
- Eurobio Scientific SA
- Mauna Kea Technologies SAS
- Zimmer Biomet Robotics
- Biosynex SA
For more information about this company profile visit https://www.researchandmarkets.com/r/m2hhtv
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
